New combo drug aims to tackle high cholesterol in one daily pill

NCT ID NCT03527069

Completed Disease control Sponsor: EMS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 3 trial tested a new combination drug called Cipros 10 against the standard statin Crestor in 146 adults with dyslipidemia (high cholesterol and triglycerides). The goal was to see if Cipros 10 could lower triglyceride levels more effectively. Participants took one pill daily, and researchers tracked both lab results and any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cipros 10 (a combination drug containing rosuvastatin and other agents)
What this could lead to: If successful, this could offer a new once-daily pill option to help control high triglycerides and cholesterol.
What could go wrong: This is a completed Phase 3 trial, but results are not yet published. The drug may not prove significantly better than existing statins like Crestor, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dyslipidemias hypertriglyceridemia inherited lipid metabolism disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DYSLIPIDEMIA HYPERTRIGLYCERIDEMIA

Contacts and locations

Locations

Allergisa

Campinas, São Paulo, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.